Emerging insights to lung cancer drug resistance

Lung cancer remains the malignant tumor with the highest morbidity and mortality in China, with non-small cell lung cancer (NSCLC) accounting for 80%-85% of cases. Nowadays, the treatment pattern of NSCLC has evolved toward precision management with the development of molecular targeted therapy and...

Descripción completa

Detalles Bibliográficos
Autor principal: Su, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511798/
https://www.ncbi.nlm.nih.gov/pubmed/36176761
http://dx.doi.org/10.20517/cdr.2022.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511798/
https://www.ncbi.nlm.nih.gov/pubmed/36176761
http://dx.doi.org/10.20517/cdr.2022.61

Ejemplares similares